Commentary: Importing Prescription Drugs Won’t Solve Cost Issues

Widescale drug importation from Canada, is not a practical solution to the problem of high drug costs. It is a distraction from efforts to address the real prescription drug cost drivers. Perhaps conflating its geographic size, importation proponents seem to overlook Canada’s small population, which is less than California’s. There’s no way that our neighbors to the north could supply the U.S. market—or even a handful of states—with all of its prescription drug needs.  President Trump and legislators should redirect their efforts to proposals that could actually make a difference short term and long term in lowering costs.